InvestorsHub Logo
Followers 1
Posts 132
Boards Moderated 0
Alias Born 01/14/2016

Re: None

Thursday, 05/04/2017 5:07:53 PM

Thursday, May 04, 2017 5:07:53 PM

Post# of 30352
After november FDA meeting it was stated that no new studies was required for the NDA yet shortly after they started one. Was the denial to calm down the shareholders as company was very low on cash? Atleast we now have a pretty good guess why they needed extra funding.
"Good" news are that the study should end next month and then starts the Q3/2017 when the NDA filing is due.

PuuliTuku
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News